You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HYNIC-3PRGD(2)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Esophageal Cancer Trial in Fuzhou (99mTc-3PRGD2)

Completed
  • Esophageal Cancer
  • Fuzhou, Fujian, China
    Department of Nuclear Medicine, First Affiliated Hospital of Fuj
Jul 30, 2020

Breast Cancer Trial in Fuzhou (99mTc-3PRGD2)

Completed
  • Breast Cancer
  • 99mTc-3PRGD2
  • Fuzhou, Fujian, China
    Department of Nuclear Medicine, First Affiliated Hospital of Fuj
Jul 30, 2020

Non Small Cell Lung Cancer Trial in Beijing (1.11 GBq of 177Lu-AB-3PRGD2)

Recruiting
  • Non Small Cell Lung Cancer
  • 1.11 GBq of 177Lu-AB-3PRGD2
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Oct 15, 2021

Lung Cancer Metastatic Trial in China (99mTc-3PRGD2)

Completed
  • Lung Cancer Metastatic
  • Beijing, Beijing, China
  • +3 more
Apr 25, 2022

Healthy Trial in Beijing (99mTc niacinamide polyethylene glycol bicyclic RGD peptide (99mTc-3PRGD2))

Completed
  • Healthy
  • 99mTc niacinamide polyethylene glycol bicyclic RGD peptide (99mTc-3PRGD2)
  • Beijing, China
    Peking Union Medical College Hospital
Aug 7, 2019

Neuroendocrine Tumors Trial in Porto Alegre (99m Tc - HYNIC -TOC EDDA and 111In - DTPA-octreotide)

Completed
  • Neuroendocrine Tumors
  • 99m Tc - HYNIC -TOC EDDA and 111In - DTPA-octreotide
  • Porto Alegre, Rio Grande Do Sul, Brazil
    Instituto do Cérebro do Rio Grande do Sul
Oct 1, 2020

Lung Cancer Trial in Beijing (99mTc-3PRGD2)

Unknown status
  • Lung Cancer
  • Beijing, China
    Department of Nuclear Medicine, Peking Union Medical College Hop
Apr 5, 2017

Duchenne Muscular Dystrophy Trial in Portland (NS-089/NCNP-02)

Not yet recruiting
  • Duchenne Muscular Dystrophy
  • Portland, Oregon
    Shriners Hospital for Children
Aug 16, 2023

Respiratory Viral Infection, SARS CoV 2 Infection Trial in Banjul

Active, not recruiting
  • Respiratory Viral Infection
  • SARS CoV 2 Infection
    • Banjul, Western Region, Gambia
      Field study in the West Coast Region and Kanifing Municipality C
    Jul 11, 2023

    Colonoscopy Trial in Nanjing (after ultrasound gastric assessment to ensure gastric empty, painless colonoscopy was performed

    Recruiting
    • Colonoscopy
    • after ultrasound gastric assessment to ensure gastric empty, painless colonoscopy was performed within 2 hours
    • Nanjing, Jiangsu, China
      Nanjing First Hospital
    Oct 26, 2023

    Food Effect in Healthy Participants Trial in Geelong, Melbourne (ORIC-114)

    Not yet recruiting
    • Food Effect in Healthy Participants
    • Geelong, Victoria, Australia
    • +1 more
    Aug 22, 2023

    COVID-19 Trial in United States (XBB.1.5 Vaccine (Booster), XBB.1.5 Vaccine (single dose))

    Not yet recruiting
    • COVID-19
    • XBB.1.5 Vaccine (Booster)
    • XBB.1.5 Vaccine (single dose)
    • Mobile, Alabama
    • +29 more
    Aug 4, 2023

    COVID-19 Trial in Thái Bình (COVIVAC vaccine)

    Completed
    • COVID-19
    • COVIVAC vaccine
    • Thái Bình, Thai Binh, Vietnam
      District Health Center of Vu Thu District
    Jul 12, 2023

    Prodromal Alzheimer's Disease, Alzheimer, Mild Cognitive Impairment Trial in Solna (LCHF, HCLF)

    Recruiting
    • Prodromal Alzheimer's Disease
    • +3 more
    • LCHF
    • HCLF
    • Solna, Sweden
      Karolinska University Hospital
    Oct 23, 2023

    Visual Acuity Trial in Jacksonville, Saint Augustine (Blink® Tears eye drops, Investigational lipid eye drops)

    Completed
    • Visual Acuity
    • Blink® Tears eye drops
    • Investigational lipid eye drops
    • Jacksonville, Florida
    • +1 more
    Nov 9, 2023

    SGLT-2 Inhibitors on Epicardial Adipose Tissue and Cardiac

    Recruiting
    • Coronary Artery Disease
    • Sodium Glucose Co-transporter 2 (SGLT2) Inhibitor
    • Shah Alam, Selangor, Malaysia
      Institute for Clinical Research, National Institutes of Health,
    Nov 9, 2023

    Fatty Liver, Nonalcoholic Trial (SGLT2 inhibitor)

    Not yet recruiting
    • Fatty Liver, Nonalcoholic
    • SGLT2 inhibitor
    • (no location specified)
    Oct 31, 2023

    Alcohol Use Disorder Trial (Prazosin + cyproheptadine, KT110)

    Not yet recruiting
    • Alcohol Use Disorder
    • Prazosin + cyproheptadine
    • KT110
    • (no location specified)
    Nov 27, 2023

    Colorectal Cancer, Clostridioides Difficile Infection, Diarrhea Trial in Koscierzyna (Sanprobi IBS®)

    Recruiting
    • Colorectal Cancer
    • +2 more
    • Sanprobi IBS®
    • Kościerzyna, Poland
      Unit of Surgery with Unit of Oncological Surgery in Koscierzyna
    Aug 24, 2023

    Healthy Trial in Salaya (Bilateral-Transcranial direct current stimulation (bilateral-tDCS), Cathodal-Transcranial direct

    Recruiting
    • Healthy
    • Bilateral-Transcranial direct current stimulation (bilateral-tDCS)
    • +3 more
    • Salaya, Nakonpathom, Thailand
      Faculty of Physical Therapy, Mahidol University
    Jun 30, 2023

    COVID-19 Trial in United States (mRNA-CR-04 vaccine 10µg, mRNA-CR-04 vaccine 30µg, mRNA-CR-04 vaccine 100µg)

    Not yet recruiting
    • COVID-19
    • mRNA-CR-04 vaccine 10μg
    • +3 more
    • San Diego, California
    • +3 more
    Aug 1, 2023

    COVID-19 Vaccine, COVID-19 Trial in Bangkok (50 µg Baiya SARS-CoV-2 Vax 2, Placebo)

    Not yet recruiting
    • COVID-19 Vaccine
    • COVID-19
    • 50 μg Baiya SARS-CoV-2 Vax 2
    • Placebo
    • Bangkok, Thailand
      Queen Saovabha Memorial Institute
    May 23, 2023

    Non-muscle Invasive Bladder Cancer Trial (TARA-002)

    Not yet recruiting
    • Non-muscle Invasive Bladder Cancer
    • TARA-002
    • (no location specified)
    Jul 14, 2023

    sTREM-1, sTREM-2, Presepsin, and Periodontitis

    Not yet recruiting
    • Periodontal Diseases
    • Periodontitis
    • no intervention
    • Erzurum, Turkey
      Atatürk University
    Jun 21, 2023

    Facio-Scapulo-Humeral Dystrophy Trial (ARO-DUX4 for Injection, Placebo)

    Not yet recruiting
    • Facio-Scapulo-Humeral Dystrophy
    • ARO-DUX4 for Injection
    • Placebo
    • (no location specified)
    Nov 13, 2023